SFH

Pathology Software Algorithm Device Analyzing Digital Images For Cancer Prognosis

Product code
SFH
Device name
Pathology Software Algorithm Device Analyzing Digital Images For Cancer Prognosis
Device class
Class 2
21 CFR
21 CFR 864.3755
Medical specialty
Pathology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1

FDA classification definition

A pathology software algorithm device analyzing digital images for cancer prognosis is a software intended to analyze scanned whole slide images (WSIs) from prostate biopsies prepared from formalin fixed paraffin-embedded (FFPE) tissue and stained using Hematoxylin & Eosin (H&E) stains. The device provides prognostic risk estimates which are intended to assist physicians with prognostic risk-based decisions along with other clinicopathological factors. The device is not intended to determine a clinical diagnosis.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-07-31.

NumberDecision dateApplicantDevice name
DEN2400682025-07-31Artera, Inc.ArteraAI Prostate
Official FDA classification page: SFH
Classification and pathway per current FDA publications. Data from openFDA (CC0).